TBRG4: A Potential Drug Target and Biomarker for Fasting-Induced Cellular Metabolism

Target Name: TBRG4

NCBI ID: G9238

TBRG4

TBRG4: A Potential Drug Target and Biomarker for Fasting-Induced Cellular Metabolism

Introduction

Fasting-induced cellular metabolism has been shown to have a wide range of physiological effects, including the regulation of metabolism, cell growth, and cell death. TBRG4, aFAST kinase domain-containing protein 4 (isoform 1), has been identified as a potential drug target and biomarker for fasting-induced cellular metabolism.

In this article, we will provide an overview of TBRG4, its functions, and potential as a drug target. We will discuss the current research on TBRG4 and its potential clinical applications, including its potential as a drug target for the treatment of various diseases, such as obesity, diabetes, and cancer.

Overview of TBRG4

TBRG4 is a protein that belongs to the FAST/KATP-ATPase family. This family is known for its role in cell signaling and metabolism, including the regulation of ATPase activity and the regulation of cellular metabolism. TBRG4 is characterized by a FAST domain, which is responsible for its kinase activity, and a KATP-ATPase domain, which is responsible for its ATPase activity.

TBRG4 is expressed in various tissues and cells, including muscle, heart, brain, and cancer cells. It has been shown to play a role in the regulation of cellular metabolism, including the regulation of glucose metabolism and the regulation of lipid metabolism. TBRG4 has has also been shown to play a role in the regulation of cell signaling pathways, including the PI3K/Akt signaling pathway.

Potential Drug Target and Biomarker

TBRG4 has been identified as a potential drug target for the treatment of various diseases, including obesity, diabetes, and cancer. The current research on TBRG4 suggests that TBRG4 plays a role in the regulation of cellular metabolism and cell signaling pathways, and that it may be a useful target for the treatment of diseases that are characterized by the disruption of cellular metabolism.

One of the potential mechanisms by which TBRG4 may be targeted as a drug is its role in the regulation of cellular metabolism. The disruption of cellular metabolism has been shown to be a common feature of various diseases, including obesity, diabetes, and cancer. TBRG4 has been shown to play a role in the regulation of cellular metabolism, including the regulation of glucose metabolism and the regulation of lipid metabolism.

In addition to its potential role as a drug target, TBRG4 has also been identified as a potential biomarker for the assessment of cellular metabolism. The disruption of cellular metabolism has been shown to be associated with the development of various diseases, including obesity, diabetes, and cancer. TBRG4 has been shown to be expressed in various tissues and cells, including muscle, heart, brain, and cancer cells, and has been shown to play a role in the regulation of cellular metabolism.

Potential Therapeutic Applications

TBRG4 has the potential to be a useful drug target for the treatment of various diseases, including obesity, diabetes, and cancer. The current research on TBRG4 suggests that TBRG4 plays a role in the regulation of cellular metabolism and cell signaling pathways, and that it may be a useful target for the treatment of diseases that are characterized by the disruption of cellular metabolism.

One of the potential therapeutic applications of TBRG4 is its potential as a drug for the treatment of obesity. Obesity is a condition characterized by the accumulation of excess body weight, and it is a leading cause of various diseases, including diabetes, cardiovascular disease, and cancer. TBRG4 has been shown to play a role in the regulation of cellular metabolism, including the regulation of glucose metabolism and the regulation of lipid metabolism. Therefore, TBRG4 may be a useful target for the treatment

Protein Name: Transforming Growth Factor Beta Regulator 4

Functions: Plays a role in processing of mitochondrial RNA precursors and in stabilization of a subset of mature mitochondrial RNA species, such as MT-CO1, MT-CO2, MT-CYB, MT-CO3, MT-ND3, MT-ND5 and MT-ATP8/6. May play a role in cell cycle progression (PubMed:9383053)

The "TBRG4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TBRG4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets